§ 15-601
342 words·~2 min read·
/md/health-general/15-601A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
§15–601.
(a)In this subtitle the following words have the meanings indicated.
(b)“Board” means the State Board of Pharmacy.
(c)“Dispense” means to provide:
(1)A prescription drug or medical supply in accordance with a prescription; or
(2)An over–the–counter drug or medical supply.
(d)“Drop–off site” means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:
(1)Has voluntarily agreed to accept donated prescription drugs, over–the–counter drugs, or medical supplies;
(2)Is located within the State or in another state; and
(3)Does not have a final disciplinary order issued against it by a health occupations board.
(e)“Eligible patient” means an individual who, through self–attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.
(f)“Program” means the Prescription Drug Repository Program.
(g)“Repository” means a licensed pharmacy that:
(1)If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;
(2)Has voluntarily agreed to participate in the Program;
(3)Is located in the State or in another state; and
(4)Has been approved by the Board to:
(i)Accept donated prescription drugs, over–the–counter drugs, or medical supplies from a designated drop–off site;
(ii)Dispense the donated prescription drugs, over–the–counter drugs, or medical supplies to eligible patients; or
(iii)Dispose of prescription drugs, over–the–counter drugs, or medical supplies not accepted for dispensing to eligible patients.
(h)“Tamper–evident packaging” means a packaging system that:
(1)May involve an immediate–container and closure system, secondary–container or carton system, tertiary–container system, or other combination of systems intended to provide a visual indication of package integrity;
(2)May contain unit–dose or multi–dose contents; and
(3)Has one or more indicators or barriers to entry that:
(i)If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and
(ii)If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.